Science NewsSubscribe to our RSS

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
STROKE | Editor's Picks | June 2020
06/04/2020 | Stroke Editor's Picks for June 2020
Cardiac Amyloidosis: Evolving Diagnosis and Management
06/01/2020 | This scientific statement is intended to inform clinical practice and facilitate management of transthyretin cardiac amyloidosis (ATTR-CM). The statement covers current diagnostic and treatment strategies while also identifying the lingering areas of uncertainty.
AHA Journals This Week | June 1, 2020
06/01/2020 | AHA Journals This Week May 26, 2020
Cardiovascular Disease in American Indians and Alaskan Natives
05/28/2020 | The prevalence of cardiovascular disease (CVD) has been rising in American Indians and Alaskan Natives; CVD is the leading cause of death in those population groups over the past 50 years.
ATVB | Featured Articles | June 2020
05/28/2020 | ATVB June 2020 Editor's Pick and Featured Article
From Circulation Research: Obesity, Metabolic Syndrome, and CVD Compendium
05/26/2020 | CIRCULATION RESEARCH Obesity, Metabolic Syndrome, and CVD
Collaboration with LLNL shares COVID-19 research data
05/22/2020 | The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
JAHA | Featured Articles | May 18, 2020
05/22/2020 | New featured articles from JAHA for May 18, 2020